Found: 7
Select item for more details and to access through your institution.
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 526, doi. 10.3390/jpm12040526
- By:
- Publication type:
- Article
Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of SARS‐CoV‐2 Infection (COVID‐19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1358, doi. 10.1002/cpt.2412
- By:
- Publication type:
- Article
Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva Cocktail.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1668, doi. 10.1002/cpt.2146
- By:
- Publication type:
- Article
Role of P-glycoprotein in the Uptake/Efflux Transport of Oral Vitamin K Antagonists and Rivaroxaban through the Caco-2 Cell Model.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, n. 4, p. 259, doi. 10.1111/bcpt.12084
- By:
- Publication type:
- Article
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 1, p. 30, doi. 10.1002/psp4.12730
- By:
- Publication type:
- Article
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites.
- Published in:
- 2018
- By:
- Publication type:
- journal article